ArticleOpen respiratory archives
High Ferritin Predicts Mortality in Patients With Interstitial Pneumonia and an Underlying Autoimmune Disease.
Article in Open respiratory archives. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To identify early predictive markers in patients with chronic interstitial pneumonia (IP) associated with an underlying autoimmune disease (AIP), aiming to facilitate personalized follow-up and treatment. Methods: We assessed the predictive value of process and host factors on mortality in a cohort of 124 patients (86 women) with autoimmune interstitial pneumonia (AIP). This cohort comprised 66 cases of connective tissue disease-associated interstitial pneumonia (CTD-IP), 40 patients with interstitial pneumonia with autoimmune features (IPAF), and 18 patients with undifferentiated autoimmune IP. All patients had a minimum follow-up of 2 years or a fatal outcome. We included demographics, clinical diagnostic subgroups, specific antibodies, morphological patterns, and relevant laboratory tests in our analysis. For the bivariate analysis, we employed Student's Results: During the follow-up period, there were 29 deaths, resulting in an incidence rate of 3.09 per 100 patient-year. Factors associated with an increased risk of death included older age at diagnosis, cardio-respiratory comorbidities, and a simultaneous onset of intersticial pneumonia and systemic manifestations. In contrast, clinical diagnosis and radiographic patterns did not show a significant association with mortality risk. Additionally, elevated levels of lactate dehydrogenase, sedimentation rate, C-reactive protein, and ferritin were significantly linked to fatal outcomes. Among these, ferritin emerged as the most potent predictor in the multivariate model, with an odds ratio of 5.9 ( Conclusion: Our data emphasize the importance of monitoring inflammatory markers, particularly ferritin levels, to assess prognosis across various subtypes of autoimmune intersticial pneumonia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.